First-in-Human Study of MOTHER-DAUGHTER DES System for PCI Bifurcation Lesions
The study evaluates the feasibility of the MOTHER-DAUGHTER side-branch access drug-eluting stent system in patients undergoing PCI.
Asset / Drug
Drug and asset intelligence for MOTHER-DAUGHTER DES with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.